KDM6A and neurodegenerative disease: Next, we investigated whether Kdm6a affected the RGC survival with two widely used in vivo cell death models, including the ONC and the NMDA receptor‐mediated excitotoxicity, a shared pathological pathway of neurodegenerative diseases.